|
Name
|
Auflagedatum
|
Volumen
|
YTD-P
|
1-Y-P
|
3-Y-P
|
5-Y-P
|
|
RH&PARTNER Investment Funds - RH&P Global Life Sciences Fund
LU0115986761
USD / Acc. / Retail
|
06.09.2000
25,9 Jahre
|
65,99 |
+15,23% |
+42,47% |
+34,78% |
+18,69% |
|
L&G Pharma Breakthrough UCITS ETF
IE00BF0H7608
USD / Acc. / Retail
|
18.01.2018
8,5 Jahre
|
17,90 |
+12,40% |
+45,00% |
+31,83% |
+17,33% |
|
Allianz Biotechnologie
DE0008481862
EUR / Dist. / Retail
|
09.01.1998
28,6 Jahre
|
287,17 |
+12,48% |
+49,62% |
+35,99% |
+25,04% |
|
DWS ESG Biotech
DE0009769976
EUR / Acc. / Retail
|
16.08.1999
27,0 Jahre
|
375,92 |
+9,46% |
+50,14% |
+44,36% |
+31,72% |
|
ERSTE STOCK BIOTEC
AT0000746755
EUR / Acc. / Retail
|
17.04.2000
26,3 Jahre
|
286,43 |
+11,88% |
+52,57% |
+48,19% |
+34,69% |
|
Protea Fund - Sectoral Biotech Opportunities Fund
LU1176840327
USD / Acc. / Retail
|
27.02.2015
11,4 Jahre
|
26,52 |
+9,99% |
+52,76% |
+37,64% |
+14,77% |
|
JPMorgan Funds - Thematics - Genetic Therapies Fund
LU2050612402
USD / Acc. / Retail
|
24.10.2019
6,8 Jahre
|
354,68 |
+17,62% |
+56,04% |
+19,19% |
-24,24% |
|
HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund
LU1540961759
USD / Acc. / Retail
|
30.12.2011
14,6 Jahre
|
22,59 |
+13,96% |
+59,29% |
+62,23% |
+40,95% |
|
iShares Nasdaq US Biotechnology UCITS ETF
IE00BYXG2H39
USD / Acc. / Retail
|
19.10.2017
8,8 Jahre
|
935,51 |
+18,29% |
+59,69% |
+55,32% |
+34,77% |
|
Invesco NASDAQ Biotech UCITS ETF
IE00BQ70R696
USD / Acc. / Retail
|
06.11.2014
11,7 Jahre
|
406,70 |
+18,31% |
+59,80% |
+55,37% |
+34,86% |